"It is plain that our clients were blocked from your account on the basis of their viewpoints," the Knight First Amendment Institute says in a letter to the White House
NYS Entity Status
NYS Filing Date
MARCH 07, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - J & I PHARMACY CORP.
Around the Web
- Trump Accused Of Violating Constitution By Blocking Twitter Users
Wednesday Jun 7, 2017
- A High School Without Textbooks
Tuesday Oct 8, 2013
Archbishop Stepinac High School, in White Plains, N.Y., is one of the first schools in the U.S. to do away with paper textbooks. Instead, the all-boys prep school requires students to use tablets and laptops in class. (Data provided by Statista.com.)
- biosimilar drugs can be a hard sell
By Jared S. Hopkins - Tuesday Aug 15, 2017
Part of the problem: a web of relationships between drug companies and insurers that shields incumbent drugs and often sidelines upstarts until the market becomes crowded.Pfizer said this month that Inflectra, its version of the blockbuster Johnson & Johnson rheumatoid arthritis drug Remicade, brought in $94 million in the second quarter.J&J spokeswoman Caroline Pavis said in a statement that Remicade is sold in a highly competitive market and that health plans decide on coverage.Doctors and patients tend to be loyal to innovative drugs that have worked well, payers are cautious in adopting alternatives, and Biosimilars can’t be swapped at the pharmacy because they aren’t identical to the drugs they are designed to replace.Remicade, known as infliximab and approved in the U.S. in 1998 for treating the digestive disorder Crohn’s disease, was cleared for rheumatoid arthritis a year later.J&J has exclusive contracts in nearly half its market, according to analyst Ronny Gal of Sanford Bernstein & Co., meaning payers agree to cover only Remicade for rheumatoid arthritis.When Sandoz released white-blood-cell booster Zarxio, the first biosimilar approved in the U.S., two years ago, it cost 15 percent less than Amgen’s Neupogen.[...] Neupogen has gradually lost its dominance, with sales sliding from $1.4 billion in 2013 to $765 million last year.[...] another similar drug, Granix by Teva Pharmaceutical, has been cleared, and Express Scripts last week became the second pharmacy-benefit manager to exclude Neupogen from its list of covered medicines.[...] Kay’s hospital found Inflectra cost $25 more than Remicade a vial, a discrepancy he attributes to pricing negotiations involving the supply chain.Makers of name-brand drugs once opposed biosimilars, citing safety among other concerns, but now say they have the manufacturing muscle and experience to produce and distribute the drugs.“For 20 years, until maybe this year, the brand industry’s position was, ‘Don’t take a biosimilar, it’s scary, it’s dangerous,’” said Bruce Leicher, senior vice president and general counsel at Momenta Pharmaceuticals, which sells generics and is developing Biosimilars.
- Rare baby white koala looks for a name on Facebook
By Yvette Tan - Tuesday Aug 22, 2017
This adorable rare white koala needs your help to find her new name.
The little joey is among several koalas born at an Australian zoo in recent months, but has only recently emerged from her mother's pouch.
She is the first white koala ever to be born in Queensland's Australia Zoo.
The female koala, who has light fur, does not have albinism but owes her pale colouration to a recessive gene, thought to be inherited from her mother.
However, her white fur might not last forever. Read more...More about Australia, Queensland, Australia Zoo, White Koala, and Baby Koala
- Presidents Cup: Telecast from N.J. did not leave viewers in N.Y. state of mind
By Martin Kaufmann - Thursday Sep 28, 2017
Some thoughts on Day 1 TV coverage of the Presidents Cup: Earlier this week I was listening to a former colleague discuss his lack of (...)
- Justin Bieber is getting into the plain white tee business
By Martha Tesema - Thursday Aug 3, 2017
Justin Bieber understands the timeless demand for classic white tees, and how hard it is to find the perfect one.
He's here to fill that hole in the marketplace with exactly what you need, because, well, what else is he supposed to do now that he's not on tour?
The singer is partnering with Hanes and celebrity stylist Karla Welch to bring a variety of white t-shirts to the masses for an impressive cost of $30.
Nah, this is not a joke.
The collaboration came into fruition when Bieber approached Welch and asked for a white shirt albeit slightly longer than the normal. According to Vogue, Welch went to town with a bunch of Hanes shirts and resurfaced with exactly what Bieber needed. That spurred a realization that well, if Bieber wants it then others might as well. Read more...More about Fashion, Justin Bieber, White T Shirt, Culture, and Web Culture